Four Seasons Ventures

FSV’s pipeline originates inside US Government laboratories, specifically research funded for national security purposes. The firm identifies technologies that have cleared early scientific risk but lack a commercial champion, then works alongside federal agencies to structure a transition. This sourcing model is closed to most allocators and dependent on relationships with lab technology-transfer offices and program managers.

The “valley of death” describes the funding gap between a government lab’s proof-of-concept and a venture-backed commercial product. FSV targets that gap by injecting private capital and installing a management team while preserving ongoing agency support. This sequencing aims to position IP for commercial sales or further private financing without stalling in the lab.

No. The firm’s website states explicitly that it is not making any new investments at this time. No additional detail on timing, fund-raising, or investment horizon accompanies that statement.

FSV targets technology verticals that emerge from national security research: advanced materials and hardware, artificial intelligence and machine learning, cybersecurity, industrial sensing and robotics, and space-adjacent platforms. The firm does not publish a public portfolio or sector-exclusion list.

FSV has not publicly disclosed its principals or investment committee members. No team page, LinkedIn profiles, or press releases name individuals managing the firm’s capital or deal evaluations.